New York City, NY -- (SBWIRE) -- 12/11/2013 -- StockMarketIntel.com issues a special report on the following stocks: Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA), Facebook Inc (NASDAQ:FB), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), FreeSeas Inc (NASDAQ:FREE)
Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA) gained 6.00%, trading on 14.02 million shares, to end the trade at $2.65. The stock changed hands in a range of $2.50 to $2.65, bringing its market capitalization to about $3.07 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.25 and was moved to the maximum level of $5.44. Federal National Mortgage Association Fannie Mae is a government-sponsored enterprise (GSE) chartered by the United States Congress to support liquidity and stability in the secondary mortgage market, where mortgage-related assets are purchased and sold.
Will FNMA Continue To Move Higher? Find Out Here
Facebook Inc (NASDAQ:FB) added 2.88%, to complete the trading session at $50.24, with a total volume of 68.47 million shares. The stock, on average, trades on a volume of 72.51million shares. It floated in a range of $48.54 to $50.77. Its market capitalization now moved to about $112.36 billion. In the past 52 weeks, the share price has not declined below $22.67 and above $54.83. Facebook, Inc. (Facebook) is engaged in building products to create utility for users, developers, and advertisers. People use Facebook to stay connected with their friends and family, to discover what is going on in the world around them, and to share and express what matters to them to the people they care about. Developers can use the Facebook Platform to build applications and Websites that integrate with Facebook to reach its global network of users and to build personalized and social products. It offers advertisers a combination of reach, relevance, social context and engagement.
Why Should Investors Buy FB After The Recent Gain? Just Go Here and Find Out
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) recorded a gain of 3.50% and was in a range of $4.38-$4.85 before closing at $4.44. The stock completed the day with a total volume of 19.06 million shares, versus an average volume of 23.20million shares. The share price hit its 52-week low of $2.15 and $24.59 was the best price. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia that is resistant or intolerant to prior TKI therapy.
What was the Moving Force behind ARIA on Bullish Run? Read This Research Report
FreeSeas Inc (NASDAQ:FREE) declined -7.69% yesterday, bringing its market capitalization around $142,034. The share price, after opening at $1.17, made a high of $1.17 and hovered above $1.05 to end the day at $1.08. The total number of shares that changed hands during the session was 1.35 million shares, as compared to average trading volume of 1.36 million shares. FreeSeas Inc. (FreeSeas) is a parent holding company of its ship-owning companies. The Company’s fleet consists of six Handysize vessels and one Handymax vessel that carry a variety of drybulk commodities, including iron ore, grain and coal, which are referred to as bulks, as well as bauxite, phosphate, fertilizers, steel products, cement, sugar and rice, or minor bulks.
Will FREE Get Buyers Even After The Recent Rally? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)